{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:21:51Z","timestamp":1779938511327,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470363"],"award-info":[{"award-number":["82470363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["BJ-2025-161, BJ-2024-150"],"award-info":[{"award-number":["BJ-2025-161, BJ-2024-150"]}]},{"name":"Beijing Model Research Wards"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Knee osteoarthritis (KOA) is a leading cause of chronic pain and disability. Metabolic dysfunction-associated fatty liver disease (MAFLD) is a systemic metabolic disorder that influences extra-hepatic conditions. Although cross-sectional studies link MAFLD to KOA, prospective evidence remains limited. This study aimed to investigate the longitudinal association between MAFLD, and KOA and assess the mediating role of inflammation. This study included 303,604 participants from the UK Biobank without baseline osteoarthritis. MAFLD was defined using the fatty liver index alongside metabolic criteria, fibrosis severity was assessed using the Fibrosis-4 score, and MAFLD subtypes were categorized. Incident KOA was identified through linked health records. Cox proportional hazard regression model was used to estimate hazard ratios (HR) and 95% confidence interval (CI) for the association. Mediation analysis evaluated the potential role of high-sensitivity C-reactive protein (hs-CRP). Over a median follow-up of 13.67 years, 17,137 KOA cases occurred. MAFLD was associated with an 18% higher risk of KOA (HR 1.18, 95% CI 1.13\u20131.24), with risk increasing by fibrosis severity (P for trend\u2009&lt;\u20090.001). Among subtypes, MAFLD-overweight\/obesity showed a significant association with KOA (HR 1.19, 95% CI 1.14\u20131.25), while MAFLD-diabetes (HR 1.05, 95% CI 0.96\u20131.16) and MAFLD-lean (HR 1.23, 95% CI 0.93\u20131.62) did not reach statistical significance. Additionally, hs-CRP explained 8.94% of the association between MAFLD and KOA. MAFLD was independently associated with higher KOA risk; inflammation partially mediates this association. These findings suggest MAFLD as a systemic metabolic condition affecting musculoskeletal health, supporting integrated management strategies.<\/jats:p>","DOI":"10.1007\/s10238-026-02096-5","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:55:52Z","timestamp":1772708152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic dysfunction-associated fatty liver disease and risk of knee osteoarthritis: A prospective cohort study"],"prefix":"10.1007","volume":"26","author":[{"given":"Yongchun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"2","key":"2096_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","volume":"104","author":"B Abramoff","year":"2020","unstructured":"Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin North Am. 2020;104(2):293\u2013311.","journal-title":"Med Clin North Am"},{"issue":"1","key":"2096_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1186\/s13018-025-06140-0","volume":"20","author":"Y Ouyang","year":"2025","unstructured":"Ouyang Y, Dai M. Global, regional, and National burden of knee osteoarthritis: findings from the global burden of disease study 2021 and projections to 2045. J Orthop Surg Res. 2025;20(1):766.","journal-title":"J Orthop Surg Res"},{"issue":"9","key":"2096_CR3","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"GBD 2021 Osteoarthritis Collaborators","year":"2023","unstructured":"GBD 2021 Osteoarthritis Collaborators. Global, regional, and National burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the global burden of disease study 2021. Lancet Rheumatol. 2023;5(9):e508\u201322.","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"2096_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.joca.2021.05.007","volume":"30","author":"VP Leifer","year":"2022","unstructured":"Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthritis Cartilage. 2022;30(1):10\u20136.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"2096_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41584-021-00673-4","volume":"17","author":"A Mahmoudian","year":"2021","unstructured":"Mahmoudian A, Lohmander LS, Mobasheri A, Englund M, Luyten FP. Early-stage symptomatic osteoarthritis of the knee - time for action. Nat Rev Rheumatol. 2021;17(10):621\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"suppl4","key":"2096_CR6","doi-asserted-by":"publisher","first-page":"iv34","DOI":"10.1093\/rheumatology\/kex417","volume":"57","author":"LA Deveza","year":"2018","unstructured":"Deveza LA, Loeser RF. Is osteoarthritis one disease or a collection of many? Rheumatology (Oxford). 2018;57(suppl4):iv34\u201342.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2096_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","volume":"11","author":"S Tang","year":"2025","unstructured":"Tang S, Zhang C, Oo WM, Fu K, Risberg MA, Bierma-Zeinstra SM, et al. Osteoarthr Nat Rev Dis Primers. 2025;11(1):10.","journal-title":"Osteoarthr Nat Rev Dis Primers"},{"issue":"3","key":"2096_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.rehab.2016.01.006","volume":"59","author":"C Palazzo","year":"2016","unstructured":"Palazzo C, Nguyen C, Lefevre-Colau MM, Rannou F, Poiraudeau S. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med. 2016;59(3):134\u20138.","journal-title":"Ann Phys Rehabil Med"},{"issue":"11","key":"2096_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.autrev.2018.06.002","volume":"17","author":"A Bortoluzzi","year":"2018","unstructured":"Bortoluzzi A, Furini F, Scir\u00e8 CA. Osteoarthritis and its management - epidemiology, nutritional aspects and environmental factors. Autoimmun Rev. 2018;17(11):1097\u2013104.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2096_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.joca.2021.06.013","volume":"30","author":"A Batushansky","year":"2022","unstructured":"Batushansky A, Zhu S, Komaravolu RK, South S, Mehta-D\u2019souza P, Griffin TM. Fundamentals of OA. An initiative of osteoarthritis and cartilage. Obesity and metabolic factors in OA. Osteoarthritis Cartilage. 2022;30(4):501\u201315.","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"2096_CR11","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: A Consensus-Driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999\u2013e20141.","journal-title":"Gastroenterology"},{"key":"2096_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221145549","volume":"14","author":"RM Pipitone","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, La Mantia C, Parisi S, Tulone A, et al. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023;14:20420188221145549.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"2096_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11906-023-01242-8","volume":"25","author":"OO Badmus","year":"2023","unstructured":"Badmus OO, Hinds TD, Stec DE. Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease. Curr Hypertens Rep. 2023;25(8):151\u201362.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"2096_CR14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ndt\/gfac188","volume":"38","author":"M Tanaka","year":"2023","unstructured":"Tanaka M, Mori K, Takahashi S, Higashiura Y, Ohnishi H, Hanawa N, et al. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease. Nephrol Dial Transpl. 2023;38(3):700\u201311.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"2096_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13195-024-01498-5","volume":"16","author":"X Bao","year":"2024","unstructured":"Bao X, Kang L, Yin S, Engstr\u00f6m G, Wang L, Xu W, et al. Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study. Alzheimers Res Ther. 2024;16(1):136.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2096_CR16","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10787-021-00842-7","volume":"29","author":"AL Han","year":"2021","unstructured":"Han AL. Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES). Inflammopharmacology. 2021;29(4):1111\u20138.","journal-title":"Inflammopharmacology"},{"issue":"12","key":"2096_CR17","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1111\/liv.16096","volume":"44","author":"Z Pan","year":"2024","unstructured":"Pan Z, Yilmaz Y, Al-Busafi SA, Eslam M. The MAFLD definition identifies three homogenous groups of patients. Liver Int. 2024;44(12):3287\u20139.","journal-title":"Liver Int"},{"issue":"3","key":"2096_CR18","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"issue":"2","key":"2096_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam M, Fan JG, Yu ML, Wong VWS, Cua IH, Liu CJ, et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol Int. 2025;19(2):261\u2013301.","journal-title":"Hepatol Int"},{"key":"2096_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"2096_CR21","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3390\/jcm10091877","volume":"10","author":"M Castellana","year":"2021","unstructured":"Castellana M, Donghia R, Guerra V, Procino F, Lampignano L, Castellana F, et al. Performance of fatty liver index in identifying Non-Alcoholic fatty liver disease in population Studies. A Meta-Analysis. J Clin Med. 2021;10(9):1877.","journal-title":"J Clin Med"},{"issue":"1","key":"2096_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"2096_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"key":"2096_CR24","unstructured":"UK Biobank. UK Biobank Biomarker Project \u2013 Companion Document to Accompany Serum Biomarker Data [Internet]. UK Biobank; 2019 [cited 2026 Jan 4]. Report No.: 1. Available from: https:\/\/biobank.ndph.ox.ac.uk\/showcase\/"},{"issue":"11","key":"2096_CR25","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.joca.2014.07.015","volume":"22","author":"A Turkiewicz","year":"2014","unstructured":"Turkiewicz A, Petersson IF, Bj\u00f6rk J, Hawker G, Dahlberg LE, Lohmander LS, et al. Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032. Osteoarthritis Cartilage. 2014;22(11):1826\u201332.","journal-title":"Osteoarthritis Cartilage"},{"issue":"10","key":"2096_CR26","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/art.40928","volume":"71","author":"T Funck-Brentano","year":"2019","unstructured":"Funck-Brentano T, Nethander M, Mov\u00e9rare-Skrtic S, Richette P, Ohlsson C. Causal factors for knee, hip, and hand osteoarthritis: a Mendelian randomization study in the UK biobank. Arthritis Rheumatol. 2019;71(10):1634\u201341.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"2096_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/eurheartj\/ehae406","volume":"46","author":"Z Li","year":"2025","unstructured":"Li Z, Cheng S, Guo B, Ding L, Liang Y, Shen Y, et al. Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis. Eur Heart J. 2025;46(7):649\u201364.","journal-title":"Eur Heart J"},{"issue":"1","key":"2096_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13075-024-03272-2","volume":"26","author":"Y Lu","year":"2024","unstructured":"Lu Y, Zhang J, Li H, Li T. Association of non-alcoholic fatty liver disease with self-reported osteoarthritis among the US adults. Arthritis Res Ther. 2024;26(1):40.","journal-title":"Arthritis Res Ther"},{"key":"2096_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2024.100378","volume":"79","author":"Z Lu","year":"2024","unstructured":"Lu Z, Wu S, Feng E, Chen X, Chen J, Lin F. Association between hepatic steatosis and fibrosis and arthritis among US adults: a population-based study. Clinics. 2024;79:100378.","journal-title":"Clinics"},{"issue":"3","key":"2096_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12072-023-10486-0","volume":"17","author":"S Chen","year":"2023","unstructured":"Chen S, Pang J, Huang R, Xue H, Chen X. Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK biobank participants. Hepatol Int. 2023;17(3):595\u2013605.","journal-title":"Hepatol Int"},{"issue":"4","key":"2096_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.numecd.2023.11.004","volume":"34","author":"Y Jia","year":"2024","unstructured":"Jia Y, Li Y, Yu J, Jiang W, Liu Y, Zeng R, et al. Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm. Nutr Metab Cardiovasc Dis. 2024;34(4):953\u201362.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"2096_CR32","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/ph17101354","volume":"17","author":"RB Tauil","year":"2024","unstructured":"Tauil RB, Golono PT, de Lima EP, de Alvares Goulart R, Guiguer EL, Bechara MD, et al. Metabolic-Associated fatty liver disease: the influence of oxidative Stress, Inflammation, mitochondrial Dysfunctions, and the role of polyphenols. Pharmaceuticals (Basel). 2024;17(10):1354.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2096_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","volume":"22","author":"Q Liu","year":"2023","unstructured":"Liu Q, Han M, Li M, Huang X, Feng R, Li W, et al. Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study. Lipids Health Dis. 2023;22(1):185.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2096_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12889-024-17682-z","volume":"24","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang D, Zhao J, Zhao H, Xie P, Zheng L, et al. Metabolic syndrome increases osteoarthritis risk: findings from the UK biobank prospective cohort study. BMC Public Health. 2024;24(1):233.","journal-title":"BMC Public Health"},{"issue":"1","key":"2096_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.joca.2018.09.007","volume":"27","author":"AE Kozijn","year":"2019","unstructured":"Kozijn AE, Tartjiono MT, Ravipati S, van der Ham F, Barrett DA, Mastbergen SC, et al. Human C-reactive protein aggravates osteoarthritis development in mice on a high-fat diet. Osteoarthritis Cartilage. 2019;27(1):118\u201328.","journal-title":"Osteoarthritis Cartilage"},{"issue":"5","key":"2096_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/abbs\/gmab021","volume":"53","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wei J, Li J, Cui Y, Zhou X, Xie J. Lipid metabolism in cartilage and its diseases: a concise review of the research progress. Acta Biochim Biophys Sin (Shanghai). 2021;53(5):517\u201327.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"3","key":"2096_CR37","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.4110\/in.2024.24.e15","volume":"24","author":"JS Lee","year":"2024","unstructured":"Lee JS, Kim YH, Jhun J, Na HS, Um IG, Choi JW, et al. Oxidized LDL accelerates cartilage destruction and inflammatory chondrocyte death in osteoarthritis by disrupting the TFEB-regulated autophagy-lysosome pathway. Immune Netw. 2024;24(3):e15.","journal-title":"Immune Netw"},{"key":"2096_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2147\/JIR.S499835","volume":"18","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Zhao YX, Li LF, Fan QQ, Huang BB, Du HZ, et al. Metabolism-related adipokines and metabolic diseases: their role in osteoarthritis. J Inflamm Res. 2025;18:1207\u201333.","journal-title":"J Inflamm Res"},{"issue":"2","key":"2096_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/annrheumdis-2014-206295","volume":"75","author":"W Hui","year":"2016","unstructured":"Hui W, Young DA, Rowan AD, Xu X, Cawston TE, Proctor CJ. Oxidative changes and signalling pathways are pivotal in initiating age-related changes in articular cartilage. Ann Rheum Dis. 2016;75(2):449\u201358.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2096_CR40","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1007\/s11357-025-01816-1","volume":"47","author":"M Del Rio-Moreno","year":"2025","unstructured":"Del Rio-Moreno M, Poudel SB, Stilgenbauer L, Cordoba-Chacon J, Sadagurski M, Kineman RD, et al. Liver injury severity determines skeletal deterioration: a shared pathophysiological axis between MASLD and osteoarthritis. Geroscience. 2025;47(5):6439\u201354.","journal-title":"Geroscience"},{"issue":"1","key":"2096_CR41","doi-asserted-by":"publisher","first-page":"18251","DOI":"10.1038\/s41598-025-03075-8","volume":"15","author":"ZO Khudhur","year":"2025","unstructured":"Khudhur ZO, Smail SW, Awla HK, Ahmed GB, Khdhir YO, Amin K, et al. The effects of heavy smoking on oxidative stress, inflammatory biomarkers, vascular dysfunction, and hematological indices. Sci Rep. 2025;15(1):18251.","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"2096_CR42","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s12072-024-10663-9","volume":"18","author":"SE Keating","year":"2024","unstructured":"Keating SE, Chawla Y, De A, George ES. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective. Hepatol Int. 2024;18(Suppl 2):959\u201376.","journal-title":"Hepatol Int"},{"issue":"5","key":"2096_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000042","volume":"10","author":"CL Hsu","year":"2019","unstructured":"Hsu CL, Wu FZ, Lin KH, Chen YH, Wu PC, Chen YH, et al. Role of fatty liver index and metabolic factors in the prediction of nonalcoholic fatty liver disease in a lean population receiving health checkup. Clin Transl Gastroenterol. 2019;10(5):1\u20138.","journal-title":"Clin Transl Gastroenterol"},{"issue":"10","key":"2096_CR44","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/tmi.13927","volume":"28","author":"F Lajeunesse-Trempe","year":"2023","unstructured":"Lajeunesse-Trempe F, Boit MK, Kaduka LU, De Lucia-Rolfe E, Baass A, Paquette M, et al. Validation of the fatty liver index for identifying non-alcoholic fatty liver disease in a Kenyan population. Trop Med Int Health. 2023;28(10):830\u20138.","journal-title":"Trop Med Int Health"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02096-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02096-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02096-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:01:17Z","timestamp":1773208877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02096-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2096"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02096-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (reference number 11\/NW\/0382).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"182"}}